COMPAMIR
High-Purity Fact Pipeline
© 2026 COMPAMIR | Verified Intelligence
High-Purity Fact Pipeline
Research teams led by Eva Schrezenmeier and Ali Naji
Germany and United States
June 3, 2026
Verified: June 3, 2026
"CAR-T cell therapy has successfully enabled kidney transplants for three highly sensitized patients. The therapy targets CD19 and BCMA proteins to reduce antibody levels that cause organ rejection. Patients who were previously ineligible for transplants due to immune system sensitivity are now living with new kidneys."
Author: Siddhartha Mukherjee
This Pulitzer Prize-winning book provides a profound historical and scientific context for the evolution of immunotherapy and cell-based treatments, helping readers understand the complexity of manipulating the immune system to fight disease.
As an Amazon Associate, COMPAMIR earns from qualifying purchases.